Status:
COMPLETED
BEVERLY-C: An Observational Study of Avastin (Bevacizumab) in First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Colorectal Cancer
Eligibility:
All Genders
65+ years
Brief Summary
This observational study will evaluate the efficacy and safety of Avastin (bevacizumab) in combination with fluoropyrimidine-based chemotherapy in elderly patients (\>/= 65 years of age) with newly di...
Eligibility Criteria
Inclusion
- Adult patients, \>/= 65 years of age
- Patients with newly diagnosed metastatic colorectal cancer starting first-line treatment with Avastin in combination with fluoropyrimidine-based chemotherapy according to the approved Hungarian Summary of Product Characteristics
- Patients suitable for Avastin treatment as assessed by the treating physician
Exclusion
- Any contraindications to Avastin treatment according to the Hungarian Summary of Product Characteristics
Key Trial Info
Start Date :
March 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01791140
Start Date
March 1 2011
End Date
May 1 2011
Last Update
November 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Budapest, Hungary, 1145